Ashley Haralson Vernon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastric Bypass | 11 | 2024 | 817 | 0.940 |
Why?
|
Gastroplasty | 7 | 2021 | 157 | 0.760 |
Why?
|
Obesity, Morbid | 11 | 2022 | 1276 | 0.680 |
Why?
|
Bariatric Surgery | 7 | 2024 | 986 | 0.610 |
Why?
|
Laparoscopy | 11 | 2021 | 2032 | 0.550 |
Why?
|
Diabetes Mellitus, Type 2 | 12 | 2024 | 12078 | 0.320 |
Why?
|
Appendectomy | 3 | 2012 | 430 | 0.300 |
Why?
|
Obesity | 10 | 2022 | 12870 | 0.280 |
Why?
|
Gastrectomy | 5 | 2022 | 669 | 0.230 |
Why?
|
Hernia, Hiatal | 2 | 2016 | 90 | 0.210 |
Why?
|
Weight Loss | 9 | 2019 | 2672 | 0.200 |
Why?
|
Cholic Acid | 1 | 2020 | 31 | 0.180 |
Why?
|
Appendicitis | 2 | 2006 | 674 | 0.180 |
Why?
|
Insufflation | 1 | 2020 | 61 | 0.170 |
Why?
|
Comprehensive Health Care | 1 | 2020 | 123 | 0.170 |
Why?
|
Digestive System Surgical Procedures | 2 | 2004 | 573 | 0.170 |
Why?
|
Hydrocephalus, Normal Pressure | 1 | 2020 | 100 | 0.170 |
Why?
|
Immunologic Surveillance | 1 | 2018 | 92 | 0.150 |
Why?
|
Short Bowel Syndrome | 1 | 2001 | 353 | 0.150 |
Why?
|
Hypoglycemic Agents | 4 | 2019 | 3069 | 0.140 |
Why?
|
Gastroesophageal Reflux | 4 | 2016 | 816 | 0.140 |
Why?
|
Anti-Obesity Agents | 1 | 2020 | 227 | 0.140 |
Why?
|
Liver | 2 | 2021 | 7502 | 0.130 |
Why?
|
Community Health Services | 1 | 2020 | 654 | 0.130 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 559 | 0.120 |
Why?
|
Vagotomy, Proximal Gastric | 1 | 2014 | 8 | 0.120 |
Why?
|
Metabolome | 1 | 2021 | 982 | 0.120 |
Why?
|
Hospitals, Pediatric | 1 | 2003 | 1854 | 0.120 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2014 | 86 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1245 | 0.100 |
Why?
|
Intestines | 1 | 2001 | 1907 | 0.100 |
Why?
|
Bone Remodeling | 1 | 2015 | 578 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1852 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2018 | 1098 | 0.090 |
Why?
|
Intussusception | 1 | 2012 | 115 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2016 | 1064 | 0.090 |
Why?
|
Killer Cells, Natural | 1 | 2018 | 2200 | 0.080 |
Why?
|
Cost Savings | 1 | 2014 | 913 | 0.080 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2021 | 363 | 0.070 |
Why?
|
Fetal Mortality | 1 | 2007 | 19 | 0.070 |
Why?
|
Task Performance and Analysis | 1 | 2012 | 759 | 0.070 |
Why?
|
Reoperation | 5 | 2021 | 4279 | 0.070 |
Why?
|
Biliary Tract Diseases | 1 | 2007 | 157 | 0.070 |
Why?
|
Treatment Outcome | 12 | 2024 | 64242 | 0.070 |
Why?
|
Fundoplication | 2 | 2004 | 144 | 0.070 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2007 | 231 | 0.060 |
Why?
|
Adipose Tissue, White | 1 | 2008 | 365 | 0.060 |
Why?
|
Body Mass Index | 5 | 2024 | 12868 | 0.060 |
Why?
|
Blood Glucose | 5 | 2021 | 6349 | 0.060 |
Why?
|
Specialties, Surgical | 1 | 2009 | 387 | 0.060 |
Why?
|
Pyloric Stenosis | 1 | 2004 | 28 | 0.060 |
Why?
|
Alabama | 1 | 2003 | 106 | 0.060 |
Why?
|
Pylorus | 1 | 2004 | 86 | 0.060 |
Why?
|
Retrospective Studies | 11 | 2021 | 79984 | 0.060 |
Why?
|
Male | 24 | 2024 | 358180 | 0.050 |
Why?
|
Th1 Cells | 1 | 2008 | 1031 | 0.050 |
Why?
|
Humans | 35 | 2024 | 757566 | 0.050 |
Why?
|
Middle Aged | 17 | 2024 | 219192 | 0.050 |
Why?
|
Adult | 17 | 2024 | 219725 | 0.050 |
Why?
|
Intraoperative Period | 1 | 2003 | 511 | 0.050 |
Why?
|
Gastroscopy | 1 | 2004 | 210 | 0.050 |
Why?
|
Laboratories, Hospital | 1 | 2003 | 192 | 0.050 |
Why?
|
Dipeptidases | 1 | 2021 | 38 | 0.050 |
Why?
|
Esophagoscopy | 1 | 2004 | 390 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2021 | 68 | 0.050 |
Why?
|
Esophagogastric Junction | 1 | 2004 | 341 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10135 | 0.050 |
Why?
|
Life Style | 3 | 2019 | 3886 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2021 | 125 | 0.050 |
Why?
|
Female | 22 | 2024 | 389943 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2024 | 39020 | 0.040 |
Why?
|
Germ-Free Life | 1 | 2021 | 187 | 0.040 |
Why?
|
Health Care Costs | 1 | 2014 | 3234 | 0.040 |
Why?
|
Sulfotransferases | 1 | 2021 | 149 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2008 | 3154 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2021 | 378 | 0.040 |
Why?
|
Exercise | 1 | 2016 | 5788 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2020 | 364 | 0.040 |
Why?
|
Bile | 1 | 2020 | 297 | 0.040 |
Why?
|
Mice, Obese | 1 | 2020 | 420 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 21990 | 0.040 |
Why?
|
Sulfates | 1 | 2020 | 379 | 0.040 |
Why?
|
Learning Curve | 1 | 2021 | 229 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2020 | 8545 | 0.040 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2020 | 187 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2009 | 1647 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2003 | 640 | 0.040 |
Why?
|
Ileum | 1 | 2021 | 556 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2021 | 359 | 0.040 |
Why?
|
Esophagus | 1 | 2004 | 1023 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2020 | 324 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2003 | 1668 | 0.040 |
Why?
|
Carcinoma | 1 | 2009 | 2330 | 0.040 |
Why?
|
Hospital Costs | 1 | 2003 | 949 | 0.040 |
Why?
|
Glucose Tolerance Test | 1 | 2020 | 1173 | 0.040 |
Why?
|
Human Growth Hormone | 1 | 2021 | 638 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2007 | 2904 | 0.030 |
Why?
|
Quality of Life | 4 | 2020 | 13263 | 0.030 |
Why?
|
Remission Induction | 1 | 2022 | 2390 | 0.030 |
Why?
|
Colon | 2 | 2020 | 1788 | 0.030 |
Why?
|
Hydroxycholecalciferols | 1 | 2015 | 44 | 0.030 |
Why?
|
Equipment Design | 2 | 2015 | 3502 | 0.030 |
Why?
|
Antacids | 1 | 2016 | 94 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2016 | 20499 | 0.030 |
Why?
|
Drug Costs | 1 | 2003 | 1179 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1703 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1600 | 0.030 |
Why?
|
Hepatocytes | 1 | 2021 | 1230 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 22022 | 0.030 |
Why?
|
Lost to Follow-Up | 1 | 2014 | 123 | 0.030 |
Why?
|
Postprandial Period | 1 | 2015 | 314 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2007 | 2940 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11890 | 0.030 |
Why?
|
Acute Disease | 1 | 2003 | 7225 | 0.030 |
Why?
|
Anesthesia | 1 | 2003 | 1581 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2021 | 1113 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2012 | 15532 | 0.020 |
Why?
|
Physical Fitness | 1 | 2016 | 732 | 0.020 |
Why?
|
Insulin, Long-Acting | 1 | 1991 | 58 | 0.020 |
Why?
|
Insulin Resistance | 2 | 2020 | 3941 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3432 | 0.020 |
Why?
|
Diet, Reducing | 1 | 2014 | 485 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4257 | 0.020 |
Why?
|
Mice | 4 | 2021 | 81066 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2407 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4845 | 0.020 |
Why?
|
Jejunum | 1 | 2012 | 471 | 0.020 |
Why?
|
Length of Stay | 1 | 2003 | 6384 | 0.020 |
Why?
|
Animals | 5 | 2021 | 167718 | 0.020 |
Why?
|
Young Adult | 4 | 2018 | 58755 | 0.020 |
Why?
|
General Surgery | 2 | 2012 | 1674 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2015 | 1796 | 0.020 |
Why?
|
Surgical Stapling | 1 | 2009 | 98 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10709 | 0.020 |
Why?
|
Prospective Studies | 4 | 2015 | 54092 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2021 | 4937 | 0.020 |
Why?
|
Private Practice | 1 | 2009 | 152 | 0.020 |
Why?
|
Animal Feed | 1 | 2008 | 112 | 0.020 |
Why?
|
Receptors, Interferon | 1 | 2008 | 116 | 0.020 |
Why?
|
Aged | 6 | 2020 | 167890 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2008 | 209 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2012 | 764 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1415 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5483 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2012 | 771 | 0.020 |
Why?
|
Child | 4 | 2006 | 79782 | 0.020 |
Why?
|
Canada | 1 | 2012 | 2109 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2008 | 794 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2012 | 14473 | 0.020 |
Why?
|
Lipids | 2 | 2014 | 3326 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2009 | 979 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14345 | 0.020 |
Why?
|
Rats | 1 | 2021 | 23676 | 0.020 |
Why?
|
Esophagectomy | 1 | 2009 | 465 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3793 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1750 | 0.020 |
Why?
|
Bone and Bones | 1 | 2015 | 2558 | 0.020 |
Why?
|
Pregnancy Trimester, Third | 1 | 2007 | 582 | 0.020 |
Why?
|
Health Behavior | 1 | 2016 | 2613 | 0.020 |
Why?
|
Infant | 2 | 2004 | 36045 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 2007 | 731 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2008 | 1595 | 0.010 |
Why?
|
Suture Techniques | 1 | 2009 | 771 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2014 | 2621 | 0.010 |
Why?
|
Markov Chains | 1 | 2007 | 965 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1788 | 0.010 |
Why?
|
Food Hypersensitivity | 1 | 2011 | 697 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5194 | 0.010 |
Why?
|
Workload | 1 | 2009 | 845 | 0.010 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2004 | 127 | 0.010 |
Why?
|
Intra-Abdominal Fat | 1 | 2008 | 609 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2009 | 1277 | 0.010 |
Why?
|
Thoracic Surgery | 1 | 2009 | 722 | 0.010 |
Why?
|
Surgical Wound Dehiscence | 1 | 2004 | 213 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2008 | 1436 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8426 | 0.010 |
Why?
|
Hypertrophy | 1 | 2004 | 555 | 0.010 |
Why?
|
Fetal Development | 1 | 2007 | 766 | 0.010 |
Why?
|
Adipocytes | 1 | 2008 | 1178 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2009 | 2914 | 0.010 |
Why?
|
Child, Preschool | 1 | 2003 | 42045 | 0.010 |
Why?
|
United States | 3 | 2014 | 71902 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2009 | 3510 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7927 | 0.010 |
Why?
|
Leptin | 1 | 2008 | 1590 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 2007 | 1264 | 0.010 |
Why?
|
Reference Values | 1 | 2007 | 4918 | 0.010 |
Why?
|
Risk Assessment | 2 | 2014 | 23816 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2354 | 0.010 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2012 | 1851 | 0.010 |
Why?
|
Cholesterol | 1 | 2008 | 2901 | 0.010 |
Why?
|
Postoperative Period | 1 | 2004 | 1806 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2742 | 0.010 |
Why?
|
Cohort Studies | 2 | 2014 | 41190 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10495 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2009 | 2809 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10477 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18326 | 0.010 |
Why?
|
Medical Oncology | 1 | 2009 | 2308 | 0.010 |
Why?
|
Stents | 1 | 2009 | 3162 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2007 | 1991 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2014 | 4760 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23335 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2004 | 1165 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1991 | 3432 | 0.010 |
Why?
|
Clinical Competence | 1 | 2012 | 4760 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 73708 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 13952 | 0.010 |
Why?
|
Gene Expression | 1 | 2008 | 7584 | 0.010 |
Why?
|
Adolescent | 1 | 2003 | 87819 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3524 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11082 | 0.010 |
Why?
|
Cognition | 1 | 2012 | 6952 | 0.010 |
Why?
|
Palliative Care | 1 | 2009 | 3568 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12047 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 21217 | 0.010 |
Why?
|
Macrophages | 1 | 2008 | 5732 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2004 | 3021 | 0.010 |
Why?
|
Hypertension | 1 | 2012 | 8502 | 0.010 |
Why?
|
Internship and Residency | 1 | 2012 | 5854 | 0.010 |
Why?
|
Pregnancy | 1 | 2007 | 29712 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1991 | 6525 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1991 | 6292 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1991 | 12261 | 0.000 |
Why?
|